Related Experiment Video
Updated: May 8, 2026
06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Intra-Aortic Balloon Pump (IABP) in cardiogenic shock
1Department of Internal Medicine/Cardiology, University of Leipzig - Heart Center, Leipzig, Germany.
Current Opinion in Critical Care
|September 3, 2013
Summary
Intra-aortic balloon pumping (IABP) shows no survival benefit for cardiogenic shock patients with myocardial infarction. Recent trials challenge previous recommendations, indicating IABP is not generally recommended. Further research is needed for alternative treatments.
Area of Science:
- Cardiology
- Critical Care Medicine
- Medical Devices
Background:
- Mortality rates for cardiogenic shock post-myocardial infarction remain high despite treatment advances.
- Intra-aortic balloon pumping (IABP) is a common hemodynamic support device, but lacked robust evidence for survival benefit.
Purpose of the Study:
- To review the current evidence and guidelines regarding the use of IABP in cardiogenic shock.
- To assess the impact of recent randomized trials on IABP recommendations.
Main Methods:
- Review of recent meta-analyses and large-scale randomized trials.
- Analysis of guideline changes from European and American societies.
Main Results:
- A recent meta-analysis suggested higher mortality with IABP after primary percutaneous intervention.
- A large randomized trial found no significant 30-day mortality benefit for IABP in myocardial infarction complicated by cardiogenic shock.
- Guideline recommendations for IABP in cardiogenic shock have been downgraded.
Conclusions:
- No general recommendation for IABP in cardiogenic shock can be made.
- Recent trial results should inform future guideline revisions.
- Development of alternative treatments and validated algorithms for active assist devices is necessary.
More Related Videos
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...